Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1351 AL 1365

Clinical approaches to the development of a neuroprotective therapy for PD

Olanow CW, Kieburtz K, Katz R.

Exp Neurol. 2017 Dec;298(Pt B):246-251. doi: 10.1016/j.expneurol.2017.06.018. Epub 2017 Jun 13.

Targeting urate to reduce oxidative stress in Parkinson disease

Crotty GF, Ascherio A, Schwarzschild MA.

Exp Neurol. 2017 Dec;298(Pt B):210-224. doi: 10.1016/j.expneurol.2017.06.017. Epub 2017 Jun 13.

Gene networks in neurodegenerative disorders

Recabarren D, Alarcón M.

Life Sci. 2017 Aug 15;183:83-97. doi: 10.1016/j.lfs.2017.06.009. Epub 2017 Jun 13.

The implication of neuronimmunoendocrine (NIE) modulatory network in the pathophysiologic process of Parkinson's disease

Shen Y, Guo X, Han C, Wan F, Ma K, Guo S, Wang L, Xia Y, Liu L, Lin Z, Huang J, Xiong N, Wang T.

Cell Mol Life Sci. 2017 Oct;74(20):3741-3768. doi: 10.1007/s00018-017-2549-2. Epub 2017 Jun 16.

The mechanism of neuroprotective action of natural compounds

Wąsik A, Antkiewicz-Michaluk L.

Pharmacol Rep. 2017 Oct;69(5):851-860. doi: 10.1016/j.pharep.2017.03.018. Epub 2017 Apr 30.

Gait dynamics in Pisa syndrome and Camptocormia: The role of stride length and hip kinematics

Tramonti C, Di Martino S, Unti E, Frosini D, Bonuccelli U, Rossi B, Ceravolo R, Chisari C.

Gait Posture. 2017 Sep;57:130-135. doi: 10.1016/j.gaitpost.2017.05.029. Epub 2017 Jun 10.

DCTN1-related neurodegeneration: Perry syndrome and beyond

Konno T, Ross OA, Teive HAG, Sławek J, Dickson DW, Wszolek ZK.

Parkinsonism Relat Disord. 2017 Aug;41:14-24. doi: 10.1016/j.parkreldis.2017.06.004. Epub 2017 Jun 12.

Inhibitors of Adaptor-Associated Kinase 1 (AAK1) May Treat Neuropathic Pain, Schizophrenia, Parkinson's Disease, and Other Disorders

Abdel-Magid AF.

ACS Med Chem Lett. 2017 May 26;8(6):595-597. doi: 10.1021/acsmedchemlett.7b00208. eCollection 2017 Jun 8.

Can Rehabilitation Influence the Efficiency of Control Signals in Complex Motion Strategies?

Cholewa J, Cholewa J, Gorzkowska A, Malecki A, Stanula A.

Biomed Res Int. 2017;2017:3631624. doi: 10.1155/2017/3631624. Epub 2017 May 24.

Neurodegenerative signaling factors and mechanisms in Parkinson's pathology

Goswami P, Joshi N, Singh S.

Toxicol In Vitro. 2017 Sep;43:104-112. doi: 10.1016/j.tiv.2017.06.008. Epub 2017 Jun 13.

Effectiveness of aquatic therapy for the control of pain and increased functionality in people with Parkinson's disease: a randomized clinical trial

Pérez de la Cruz S.

Eur J Phys Rehabil Med. 2017 Dec;53(6):825-832. doi: 10.23736/S1973-9087.17.04647-0. Epub 2017 Jun 19.

Folding Underlies Bidirectional Role of GPR37/Pael-R in Parkinson Disease

Leinartaité L, Svenningsson P.

Trends Pharmacol Sci. 2017 Aug;38(8):749-760. doi: 10.1016/j.tips.2017.05.006. Epub 2017 Jun 16.

Prediction of cognition in Parkinson's disease with a clinical-genetic score: a longitudinal analysis of nine cohorts

Liu G, Locascio JJ, Corvol JC, Boot B, Liao Z, Page K, Franco D, Burke K, Jansen IE, Trisini-Lipsanopoulos A, Winder-Rhodes S, Tanner CM, Lang AE, Eberly S, Elbaz A, Brice A, Mangone G, Ravina B, Shoulson I, Cormier-Dequaire F, Heutink P, van Hilten JJ, Barker RA, Williams-Gray CH, Marinus J, Scherzer CR; HBS; CamPaIGN; PICNICS; PROPARK; PSG; DIGPD; PDBP.

Lancet Neurol. 2017 Aug;16(8):620-629. doi: 10.1016/S1474-4422(17)30122-9. Epub 2017 Jun 16.

Psychosocial therapy for Parkinson's-related dementia: study protocol for the INVEST randomised controlled trial

McCormick SA, McDonald KR, Vatter S, Orgeta V, Poliakoff E, Smith S, Silverdale MA, Fu B, Leroi I.

BMJ Open. 2017 Jun 19;7(6):e016801. doi: 10.1136/bmjopen-2017-016801.

Optimizing the deep brain stimulation care pathway in patients with Parkinson's disease

Thomas NJ, Mertens P, Danaila T, Polo G, Klinger H, Broussolle E, Thobois S.

J Neurol. 2017 Jul;264(7):1454-1464. doi: 10.1007/s00415-017-8548-2. Epub 2017 Jun 19.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias